Press Releases

SEOUL, South Korea, May 29, 2024 /PRNewswire/ -- Nuvilab delivered a keynote at the Aramark Innova Summit 2024. This event, attended by key figures related to Aramark and potential clients, provided a platform for discussing the innovations of AI in the food service industry.

Since the London Protocol of 2006, South Korea has implemented a mandatory composting system. While this infrastructure enables the country to dispose of nearly all its food waste appropriately,... (continue reading...)

Cancer survivors encouraged to help provide feedback on best practices for supporting LGBTQ+ cancer survivors and the people who care for them

DETROIT, May 29, 2024 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute is partnering with Wayne State University (WSU) School of Medicine, the University of Rochester, and the National Institutes of Health (NIH) to bring attention to the unique needs of cancer survivors and their caregivers in the LGBTQ+ community.... (continue reading...)

SHEPHERDSTOWN, W.Va., May 29, 2024 (SEND2PRESS NEWSWIRE)  Marty and Jessica Herbert, Herbert Insights & Innovations LLC (HI&I), Shepherdstown, West Virginia, were recently named to the National Small Business Association (NSBA) Leadership Council. NSBA is the nation’s oldest small-business advocacy organization, and operates on a staunchly nonpartisan basis. Marty and Jessica, recognized leaders in the small-business community, join the NSBA Leadership Council... (continue reading...)

PLANTATION, Fla.--(BUSINESS WIRE)-- Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, has released its financial results for the first quarter of fiscal year 2024 ended April 28, 2024.

Fiscal Q1 2024 Highlights:

• Net sales of $2.88 billion increased 3.1 percent year over year
• Gross margin of 29.7 percent increased 130 basis points year over year
• Net income of $66.9 million, including share-based... (continue reading...)

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)-- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, announced initial data from the Phase 1 MINOTAUR study evaluating lunresertib (RP-6306) in combination with FOLFIRI for the treatment of advanced solid tumors has been selected for a poster presentation at the European Society of Medical Oncology (ESMO) Gastrointestinal (GI) Cancers Congress... (continue reading...)